PLEASANTON, CA -- (MARKET WIRE) -- November 08, 2006 -- Lipid Sciences, Inc. (NASDAQ: LIPD) today announced that the Company had entered into a collaborative research and license agreement with Elanco Animal Health (Elanco), a division of Eli Lilly and Company (NYSE: LLY), to research, develop, manufacture, and sell one or more immunological products for animal health applications beginning with a vaccine directed against specific lipid-enveloped organisms.
